Xixojun MA. Overview of Diagnosis and Treatment of Infectious Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(5): 393-398. doi: 10.3969/j.issn.1674-9081.2018.05.003
Citation:
Xixojun MA. Overview of Diagnosis and Treatment of Infectious Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(5): 393-398. doi: 10.3969/j.issn.1674-9081.2018.05.003
Xixojun MA. Overview of Diagnosis and Treatment of Infectious Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(5): 393-398. doi: 10.3969/j.issn.1674-9081.2018.05.003
Citation:
Xixojun MA. Overview of Diagnosis and Treatment of Infectious Diseases[J]. Medical Journal of Peking Union Medical College Hospital, 2018, 9(5): 393-398. doi: 10.3969/j.issn.1674-9081.2018.05.003
Department of Infectious Diseases, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100730
he medical development brought about by the progress of science and technology has made great contributions to the improvement of diagnosis and treatment of many diseases including infection. However, it is undeniable that infection is still an important disease threatening human beings. Even the most advanced technique of pathogen identification still cannot change the model of empirical treatment and comprehensive judgment, which is the main module of early diagnosis and treatment of infectious diseases (ID). Therefore, how to improve the comprehensive diagnosis and treatment of ID by clinicians is very important in the early diagnosis and treatment, especially in the current situation of general lack of ID specialists in our country. This article is to combine basic skills of clinical practice and international advanced experience to sort out the diagnosis and treatment of ID, in order to provide a feasible reference for clinicians.
Goto M, Schweizer ML, Vaughan-Sarrazin MS, et al.Association of Evidence-Based Care Processes With Mortality in Staphylococcus aureus Bacteremia at Veterans Health Administration Hospitals, 2003-2014[J].JAMA Intern Med, 2017, 177:1489-1497. doi: 10.1001/jamainternmed.2017.3958
[4]
Morgan DJ, Dhruva SS, Wright SM, et al. Update on Medical Practices That Should Be Questioned in 2015[J]. JAMA Intern Med, 2015, 175:1960-1964. doi: 10.1001/jamainternmed.2015.5614
Hoenigl M, Strenger V, Buzina W, et al. European Organization for the Research and Treatment of Cancer/ Mycoses Study Group (EORTC/MSG) host factors and invasive fungal infections in patients with haematological malignancies[J]. J Antimicrob Chemother, 2012, 67: 2029-2033. doi: 10.1093/jac/dks155
[7]
Drinka P, Niederman MS, El-Solh AA, et al. Assessment of risk factors for multi-drug resistant organisms to guide empiric antibiotic selection in long term care: a dilemma[J]. J Am Med Dir Assoc, 2011, 12:321-325. doi: 10.1016/j.jamda.2010.06.012
[8]
Aliberti S, Di Pasquale M, Zanaboni AM, et al. Stratifying risk factors for multidrug-resistant pathogens in hospitalized patients coming from the community with pneumonia[J]. Clin Infect Dis, 2012, 54:470-478. doi: 10.1093/cid/cir840